Abstract
Treatment of childhood cancer is one of the major success stories of modern medicine, showing the benefits of multidisciplinary, centralised treatment and high-quality supportive care. For acute lymphoblastic leukaemia (ALL)—the most common childhood cancer—overall 5-year survival is now greater than 85%. 1 Pui CH Mullighan CG Evans WE Relling MV Pediatric acute lymphoblastic leukemia: where are we going and how do we get there?. Blood. 2012; 120: 1165-1174 Crossref PubMed Scopus (399) Google Scholar Risk of late effects of treatment in children newly diagnosed with standard-risk acute lymphoblastic leukaemia: a report from the Childhood Cancer Survivor Study cohortThe prevalence of adverse long-term outcomes in children treated for standard risk acute lymphoblastic leukaemia according to contemporary protocols is low, but regular care from a knowledgeable primary-care practitioner is warranted. Full-Text PDF
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
